Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-31 Sale | 2024-07-31 9:40 pm | ARYA Sciences Acquisition Corp IV | ARYD | ALTMAN MICHAEL SETH Chief Financial Officer 10% Owner | 499,000 | $0 | $0 | 2,647,500 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-07-20 Conversion | 2026-07-22 7:18 pm | N/A N/A | Freenome Inc. | FRNM | ALTMAN MICHAEL SETH Former Dir, Ofc, 10% Ownr | 2,066,250 | $0 | 2,352,500 (Indirect) | View |
| 2024-09-27 Other | 2024-10-01 4:35 pm | N/A N/A | Adagio Medical Holdings Inc. | ADGM | ARYA Sciences Holdings IV Stone Adam Leo ALTMAN MICHAEL SETH 10% Owner | 3,501,600 | $0 | 3,501,600 (Direct) | View |
Ownership | 2024-08-01 5:16 pm | N/A N/A | Adagio Medical Holdings Inc. | ADGM | ARYA Sciences Holdings IV Stone Adam Leo ALTMAN MICHAEL SETH 10% Owner | 0 | $0 | 3,501,600 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-17 6:03 pm | N/A 2034-06-14 | Nautilus Biotechnology Inc. | NAUT | ALTMAN MICHAEL SETH Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 4:10 pm | N/A 2034-06-12 | Lyra Therapeutics Inc. | LYRA | ALTMAN MICHAEL SETH Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-13 4:37 pm | N/A N/A | Perceptive Capital Solutions Corp | PCSC | ALTMAN MICHAEL SETH Chief Business Officer 10% Owner | 286,250 | $10 | 286,250 (Indirect) | View |
Ownership | 2024-06-11 5:58 pm | N/A N/A | Perceptive Capital Solutions Corp | PCSC | ALTMAN MICHAEL SETH Chief Business Officer | 0 | $0 | 2,066,250 (Indirect) | View |
| 2023-06-30 Option Award | 2023-07-05 9:49 pm | N/A 2033-06-29 | Lyra Therapeutics Inc. | LYRA | ALTMAN MICHAEL SETH Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 8:52 pm | N/A 2033-06-15 | Nautilus Biotechnology Inc. | NAUT | ALTMAN MICHAEL SETH Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 4:06 pm | N/A 2032-06-15 | Lyra Therapeutics Inc. | LYRA | ALTMAN MICHAEL SETH Director | 7,250 | $0 | 7,250 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 5:43 pm | N/A 2032-06-15 | Nautilus Biotechnology Inc. | NAUT | ALTMAN MICHAEL SETH Director | 86,467 | $0 | 86,467 (Direct) | View |